HOME › DRUGS › OZANIMOD
ACTIVE SUBSTANCE / INN

OZANIMOD

Brand name(s): Zeposia, OZANIMOD
FDA LISTED
EMA LISTED
AUTHORISED
NONE (TENTATIVE APPROVAL)
ANDA219236
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative
ACTIVE SUBSTANCE
Ozanimod
REGULATORS
FDA · EMA
SPONSORS / MAH
Bristol-Myers Squibb Pharma EEIG, SYNTHON BV
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OZANIMODANDA219236SYNTHON BVNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZeposiaBristol-Myers Squibb Pharma EEIGAuthorised20/05/2020Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative

FULL INTELLIGENCE ON OZANIMOD

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →